Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy
For neonatal HIE, cool term infants (≥36 weeks) with moderate-to-severe encephalopathy to 33.5°C for 72 hours starting within 6 hours of birth; for adults after cardiac arrest, cool unconscious patients to 32-34°C for 12-24 hours when initial rhythm was ventricular fibrillation. 1, 2
Neonatal HIE Protocol
Patient Selection Criteria
Initiate therapeutic hypothermia for term neonates (≥36 weeks gestation) who meet ALL of the following within 6 hours of birth: 1
Biochemical evidence of peripartum hypoxic-ischemic event:
- Cord blood gas with pH <7.0 or base deficit ≥16 mmol/L
- If cord gas unavailable, obtain blood gas within first hour showing similar acidosis
Clinical evidence of moderate-to-severe encephalopathy:
- Altered consciousness (lethargy, stupor, or coma)
- Abnormal tone (hypotonia or hypertonia)
- Abnormal reflexes (absent or weak suck, Moro reflex)
- Clinical seizures
No sentinel event identification is required to initiate cooling. 1
Cooling Parameters
Target temperature: 33.5°C (rectal/esophageal) for exactly 72 hours 1
- Deeper cooling (32°C) or longer duration (120 hours) increases mortality without improving outcomes 1
- Rewarm slowly at 0.5°C per hour after 72 hours 3
- Use servo-controlled devices to maintain precise temperature control
Timing Considerations
Optimal window: Initiate within 6 hours of birth 1
Late cooling (6-24 hours): May be considered with shared decision-making if infant initially didn't meet criteria or cooling was unavailable earlier. Evidence shows only 76% probability of modest benefit (1-3% reduction in death/disability). Cool for 96 hours if starting late. 1
Transport Cooling
Use servo-controlled cooling devices during transport when arrival at cooling center within 6 hours is not feasible. 1 Passive cooling (turning off radiant warmer, applying gel packs) carries significant overcooling risk and requires continuous rectal temperature monitoring every 15 minutes. 4
Special Populations
Late preterm infants (35 0/7 to 35 6/7 weeks): Limited evidence exists. Cooling may be considered only after detailed parental discussion documenting potential risks and uncertain benefits. 1
Mild HIE: Do NOT cool outside research protocols. Insufficient evidence of benefit. 1
Required Infrastructure
Centers offering therapeutic hypothermia must provide: 1
- Mechanical ventilation capability
- Continuous temperature and vital sign monitoring
- Brain MRI before discharge
- Continuous EEG monitoring (preferred) or amplitude-integrated EEG
- 24/7 neurology consultation access
- Written protocols with outcome monitoring
- Neurodevelopmental follow-up programs
Critical Pitfalls to Avoid
- Hyperthermia prevention: Even when not cooling, avoid fever in all suspected HIE cases 1
- Overcooling: Temperature <32°C increases mortality; use servo-controlled devices 1
- Delayed identification: Educate all delivery and nursery staff on eligibility criteria 1
- Hypocarbia: Avoid during mechanical ventilation as it worsens outcomes 3
Adult Post-Cardiac Arrest Protocol
Cool unconscious adult patients with spontaneous circulation after out-of-hospital cardiac arrest to 32-34°C for 12-24 hours when initial rhythm was ventricular fibrillation. 2
Patient Selection
- Unconscious after return of spontaneous circulation (ROSC)
- Out-of-hospital cardiac arrest with witnessed VF as initial rhythm
- May also benefit patients with other rhythms or in-hospital arrest, though evidence is weaker 2
Cooling Parameters
- Target temperature: 32-34°C
- Duration: 12-24 hours
- Monitoring: Core temperature via bladder probe or pulmonary artery catheter (tympanic measurements unreliable) 2
Key Differences from Neonatal Cooling
The evidence for adult therapeutic hypothermia is substantially weaker and more inconsistent than neonatal data. 5, 6 Multiple factors explain this disparity:
- Timing constraints: Adults often receive cooling beyond the critical 4-hour window when brain injury becomes irreversible 5, 7
- Shorter treatment duration: Adult trials used 12-48 hours versus 72 hours in neonates 6
- Comorbidities: Adults have diabetes, hypertension, atherosclerosis, and active inflammation that interfere with neuroprotection 6
- Injury mechanism: Adult cardiac arrest involves more necrosis (which hypothermia doesn't prevent) versus neonatal apoptosis (which hypothermia inhibits) 6
- Population heterogeneity: Patients with minimal injury don't need cooling; those with severe irreversible injury won't benefit. Only moderate-severity patients may respond. 7
Clinical Reality
Recent large trials show inconsistent benefit in adults, unlike the robust neonatal evidence. 5 The 2003 ILCOR recommendation 2 predates these negative trials. Current practice should focus on:
- Ultra-early initiation (within 4 hours of ROSC if possible) 5, 7
- Patient stratification using neuroimaging, EEG, and biomarkers to identify moderate-severity injury 7, 8
- Avoiding fever in all comatose post-arrest patients regardless of cooling decision 5
Pediatric Considerations
Insufficient evidence exists for therapeutic hypothermia in children after cardiac arrest. 2 Historical data from near-drowning victims showed increased mortality with cooling, though these studies used deeper temperatures (30-33°C) for longer durations (36 hours) than current protocols. Tailor therapy individually based on risk-benefit assessment. 2